137 related articles for article (PubMed ID: 29163771)
21. Disruption of HOX activity leads to cell death that can be enhanced by the interference of iron uptake in malignant B cells.
Daniels TR; Neacato II; Rodríguez JA; Pandha HS; Morgan R; Penichet ML
Leukemia; 2010 Sep; 24(9):1555-65. PubMed ID: 20574452
[TBL] [Abstract][Full Text] [Related]
22. HOX deregulation in acute myeloid leukemia.
Rice KL; Licht JD
J Clin Invest; 2007 Apr; 117(4):865-8. PubMed ID: 17404613
[TBL] [Abstract][Full Text] [Related]
23. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
24. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
Calvo KR; Sykes DB; Pasillas MP; Kamps MP
Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
[TBL] [Abstract][Full Text] [Related]
25. Hox genes: from leukemia to hematopoietic stem cell expansion.
Abramovich C; Pineault N; Ohta H; Humphries RK
Ann N Y Acad Sci; 2005 Jun; 1044():109-16. PubMed ID: 15958703
[TBL] [Abstract][Full Text] [Related]
26. Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells.
Feldmann F; Schenk B; Martens S; Vandenabeele P; Fulda S
Oncotarget; 2017 Sep; 8(40):68208-68220. PubMed ID: 28978109
[TBL] [Abstract][Full Text] [Related]
27. HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia.
Whelan JT; Ludwig DL; Bertrand FE
Leukemia; 2008 Jun; 22(6):1161-9. PubMed ID: 18337761
[TBL] [Abstract][Full Text] [Related]
28. The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia.
Brumatti G; Ma C; Lalaoui N; Nguyen NY; Navarro M; Tanzer MC; Richmond J; Ghisi M; Salmon JM; Silke N; Pomilio G; Glaser SP; de Valle E; Gugasyan R; Gurthridge MA; Condon SM; Johnstone RW; Lock R; Salvesen G; Wei A; Vaux DL; Ekert PG; Silke J
Sci Transl Med; 2016 May; 8(339):339ra69. PubMed ID: 27194727
[TBL] [Abstract][Full Text] [Related]
29. Pbx3 and Meis1 cooperate through multiple mechanisms to support Hox-induced murine leukemia.
Garcia-Cuellar MP; Steger J; Füller E; Hetzner K; Slany RK
Haematologica; 2015 Jul; 100(7):905-13. PubMed ID: 25911551
[TBL] [Abstract][Full Text] [Related]
30. c-Met inhibition in a HOXA9/Meis1 model of CN-AML.
Mulgrew NM; Kettyle LM; Ramsey JM; Cull S; Smyth LJ; Mervyn DM; Bijl JJ; Thompson A
Dev Dyn; 2014 Jan; 243(1):172-81. PubMed ID: 24307265
[TBL] [Abstract][Full Text] [Related]
31. Epigenomic analysis of the HOX gene loci reveals mechanisms that may control canonical expression patterns in AML and normal hematopoietic cells.
Spencer DH; Young MA; Lamprecht TL; Helton NM; Fulton R; O'Laughlin M; Fronick C; Magrini V; Demeter RT; Miller CA; Klco JM; Wilson RK; Ley TJ
Leukemia; 2015 Jun; 29(6):1279-89. PubMed ID: 25600023
[TBL] [Abstract][Full Text] [Related]
32. Transcription factor AP-2α regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression.
Ding X; Yang Z; Zhou F; Wang F; Li X; Chen C; Li X; Hu X; Xiang S; Zhang J
Int J Biochem Cell Biol; 2013 Aug; 45(8):1647-56. PubMed ID: 23660297
[TBL] [Abstract][Full Text] [Related]
33. [Relationship between the HOX gene family and the acute myeloid leukemia-review].
Jiang Q; Liu WJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1340-4. PubMed ID: 24156462
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of cancer cell proliferation by designed peptide amphiphiles.
Aulisa L; Forraz N; McGuckin C; Hartgerink JD
Acta Biomater; 2009 Mar; 5(3):842-53. PubMed ID: 19249722
[TBL] [Abstract][Full Text] [Related]
35. Cellular proliferation and transformation induced by HOXB4 and HOXB3 proteins involves cooperation with PBX1.
Krosl J; Baban S; Krosl G; Rozenfeld S; Largman C; Sauvageau G
Oncogene; 1998 Jul; 16(26):3403-12. PubMed ID: 9692548
[TBL] [Abstract][Full Text] [Related]
36. Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression.
Camós M; Esteve J; Jares P; Colomer D; Rozman M; Villamor N; Costa D; Carrió A; Nomdedéu J; Montserrat E; Campo E
Cancer Res; 2006 Jul; 66(14):6947-54. PubMed ID: 16849538
[TBL] [Abstract][Full Text] [Related]
37. Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia.
Drabkin HA; Parsy C; Ferguson K; Guilhot F; Lacotte L; Roy L; Zeng C; Baron A; Hunger SP; Varella-Garcia M; Gemmill R; Brizard F; Brizard A; Roche J
Leukemia; 2002 Feb; 16(2):186-95. PubMed ID: 11840284
[TBL] [Abstract][Full Text] [Related]
38. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.
Huang MJ; Cheng YC; Liu CR; Lin S; Liu HE
Exp Hematol; 2006 Nov; 34(11):1480-9. PubMed ID: 17046567
[TBL] [Abstract][Full Text] [Related]
39. The role of HOXB2 and HOXB3 in acute myeloid leukemia.
Lindblad O; Chougule RA; Moharram SA; Kabir NN; Sun J; Kazi JU; Rönnstrand L
Biochem Biophys Res Commun; 2015 Nov; 467(4):742-7. PubMed ID: 26482852
[TBL] [Abstract][Full Text] [Related]
40. Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis.
Strathdee G; Holyoake TL; Sim A; Parker A; Oscier DG; Melo JV; Meyer S; Eden T; Dickinson AM; Mountford JC; Jorgensen HG; Soutar R; Brown R
Clin Cancer Res; 2007 Sep; 13(17):5048-55. PubMed ID: 17785556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
